Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-10 · accession 0001415889-23-006444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-11 | 2023-04-10 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $10.71 | -1,353 | 12.6K | -10% | -$14.5K |
| D | 2023-04-11 | 2023-04-10 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +2,477 | 13.9K | +22% | — |
| D | 2023-04-11 | 2023-04-10 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | +2,477 | 7,431 | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-04-10 | F | D | 1,353 | $10.71 | 12,553 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-04-10 | M | A | 2,477 | — | 13,906 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Derivative | Restricted Share Unit | 2023-04-10 | M | A | 2,477 | $0.00 | 7,431 | D | — · — to — | 2,477 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |